Skip to main content
LUYAN PHARMA CO.,LTD logo

LUYAN PHARMA CO.,LTD — Investor Relations & Filings

Ticker · 002788 ISIN · CNE1000025W1 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,022 across all filing types
Latest filing 2016-02-22 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002788

About LUYAN PHARMA CO.,LTD

https://www.luyan.com.cn

Luyan Pharma Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive logistics network, providing supply chain management services to healthcare institutions, including hospitals and community clinics. Its product portfolio encompasses a wide range of Western pharmaceuticals, traditional Chinese medicines, and medical equipment. In addition to wholesale distribution, the company maintains a significant presence in the retail pharmacy sector through a chain of drugstores. Luyan Pharma focuses on optimizing healthcare delivery through integrated distribution systems and value-added services, such as third-party logistics and pharmaceutical cold chain management. The organization leverages its regional market leadership to expand its service footprint and enhance the efficiency of the medical supply chain.

Recent filings

Filing Released Lang Actions
股票交易异常波动公告的更正公告
Regulatory Filings Classification · 95% confidence The document is a correction announcement regarding a previously published notice about abnormal stock price fluctuations. It clarifies an error in the calculation of the price deviation and apologizes for any inconvenience caused. The content is a regulatory announcement related to stock trading behavior and does not contain financial statements, management discussion, or detailed report data. It is a short notice correcting a prior announcement, fitting the category of a general regulatory filing rather than a full report or financial disclosure.
2016-02-22 Chinese
股票交易异常波动公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement regarding abnormal stock price fluctuations of the company 鹭燕（福建）药业股份有限公司. It includes explanations about the stock price movements, company operations, risk factors, and market conditions. The document does not contain financial statements or quarterly/yearly financial results but focuses on regulatory disclosure about stock trading anomalies and associated risks. It is not an earnings release, annual report, or interim report. It is a regulatory announcement related to stock trading and risk disclosures, fitting the category of Regulatory Filings (RNS). The document length (7584 characters) and content confirm it is a full announcement rather than a brief notice or report publication announcement.
2016-02-21 Chinese
上市首日风险提示公告
Regulatory Filings Classification · 95% confidence The document is a risk warning announcement related to the company's first day of stock listing on the Shenzhen Stock Exchange. It includes financial data up to 2015, including audited and reviewed financial statements, but it is not a full annual or quarterly report. The document discusses risk factors, market conditions, and financial performance summaries, but it does not present a comprehensive financial report or detailed management discussion and analysis. It is a regulatory announcement informing investors about risks and the company's status at the time of IPO listing. The document length is about 7,915 characters, which is substantial but the content is more of a risk disclosure and listing announcement rather than a full financial report. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and risk disclosure related to the IPO listing, not an Annual Report or Interim Report.
2016-02-17 Chinese
国信证券股份有限公司关于公司股票上市保荐书
Regulatory Filings Classification · 95% confidence The document is titled as a "股票上市保荐书" which translates to "Stock Listing Sponsorship Letter". It is issued by Guosen Securities Co., Ltd. regarding the stock listing of Luyan (Fujian) Pharmaceutical Co., Ltd. The document includes detailed information about the company, its financial data over multiple years, stock issuance details, shareholder lock-up commitments, and the sponsor's recommendation for the company's stock listing on the Shenzhen Stock Exchange. It is a formal sponsorship letter supporting the company's initial public offering (IPO) and listing application, including compliance and due diligence statements by the sponsor. This type of document is not an annual report, earnings release, or other financial report but a regulatory filing related to the IPO process and stock listing approval. It does not fit into categories like 10-K, IR, ER, or MDA. It is a regulatory announcement related to the stock listing process and sponsorship. Therefore, the most appropriate classification is Regulatory Filings (RNS). The document length is over 10,000 characters and contains substantive content, so it is not a mere announcement of a report (RPA).
2016-02-16 Chinese
首次公开发行股票上市公告书
Regulatory Filings Classification · 95% confidence The document is titled as a "首次公开发行股票上市公告书" which translates to "Initial Public Offering (IPO) Listing Announcement". It contains detailed information about the company's IPO, including stock issuance quantity, pricing, shareholder lock-up commitments, stock listing date, underwriting details, and regulatory approvals. The document is lengthy (15,000 characters) and provides comprehensive disclosures related to the IPO process and stock listing. It is not a financial report like an annual or quarterly report, nor is it a simple announcement of a report. It is a formal regulatory filing announcing the company's stock listing and IPO details. This type of document fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories. Therefore, the classification is RNS with high confidence.
2016-02-16 Chinese
北京市金杜律师事务所关于公司首次公开发行股票并于深圳证券交易所上市的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the company's initial public offering (IPO) and listing on the Shenzhen Stock Exchange. It references Chinese securities laws, regulatory approvals from the China Securities Regulatory Commission (CSRC), shareholder meeting resolutions, issuance details, and compliance with listing rules. The document is not a financial report, earnings release, or management discussion but a legal opinion related to the IPO process and listing compliance. This type of document is typically classified as a Regulatory Filing (RNS) because it is a formal regulatory submission related to compliance and legal matters for the IPO and listing, not a financial report or announcement of voting results or capital changes. The document length (5887 characters) and content confirm it is a detailed legal opinion rather than a brief announcement or certification letter. Therefore, the best fitting category is Regulatory Filings (RNS).
2016-02-16 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.